A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1067-1072

  Nishiyama, O ^a,b   Taniguchi, H ^a   Kondoh, Y ^a   Kimura, T ^a   Kato, K ^a   Kataoka, K ^a   Ogawa, T ^a   Watanabe, F ^a   Arizono, S ^a  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dyspnoea; Idiopathic pulmonary fibrosis; Mortality

Indexed keywords

CARBON MONOXIDE;

AGED; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BORG SCALE; DAILY LIFE ACTIVITY; DYSPNEA; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SCALE; PRIORITY JOURNAL; PROGNOSIS; PULSE OXIMETRY; RATING SCALE; SPIROMETRY; SURVIVAL;

ACTIVITIES OF DAILY LIVING; AGED; DISEASE PROGRESSION; DYSPNEA; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 78349286777     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00152609     Document Type: Article

References (34)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
2. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
3. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19: 275-283.
4. King TE Jr, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-1181.
5. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063-1072.
6. Nicholson AG, Fulford LG, Colby TV, et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 173-177.
7. Xaubet A, Agusti C, Luburich P, et al. Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 431-436.
8. Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 659-664.
9. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-1090.
10. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of change in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006; 174: 803-809.
11. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537.
12. Collard HR, King TE Jr, Bartelson BB, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 538-542.
13. Flaherty KR, Mumford JA, Murrays S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 543-548.
14. Mahler DA, Rosiello RA, Harver A, et al. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive disease. Am Rev Respir Dis 1987; 135: 1229-1233.
15. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-586.
16. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
17. Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
18. Hanamoto S, Ohsuji T, Tsuyaguchi I, et al. [Prediction formulas for pulmonary function tests expressed in linear and exponential form for healthy Japanese adults.] Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30: 2051-2060.
19. American Thoracic Society. ATS statement: guidelines for six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
20. Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
21. Fell CD, Liu LX, Motika C, et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 402-407.
22. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
23. Martibez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142: 963-967.
24. Nishiyama O, Taniguchi H, Kondoh Y, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med 2005; 99: 408-414.
25. Eltayara L, Becklake MR, Volta CA, et al. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1726-1734. (Pubitemid 26424942)
26. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
27. Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of a new dyspnea measure. Chest 1998; 113: 619-624.
28. Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
29. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-180. (Pubitemid 10131195)
30. Manali ED, Stathopoulos GT, Kollintza A, et al. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir Med 2008; 102: 586-592.
31. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
32. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656. (Pubitemid 46446853)
33. Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-554. (Pubitemid 351831168)
34. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13: 394-399. (Pubitemid 351503129)